Rainbow Children's Medicare Limited Sets Q2 FY27 Call for November 2

Rainbow Children's Medicare Limited has scheduled an earnings conference call for November 2, 2026, to discuss its second-quarter FY27 performance and outlook. The company’s board is set to consider the September-quarter and half-year results on October 31, while its first-quarter revenue had risen 33% year-on-year to ₹4.70 billion.

When will Rainbow Children's Medicare announce Q2 FY27 results?

Rainbow Children's Medicare is scheduled to hold its Q2 FY27 earnings conference call at 10:00 AM IST on November 2, 2026, following the board meeting planned for October 31. The board meeting intimation states that directors will consider unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, along with other matters.

The September 2026 quarter covers the period from July 1 to September 30. Earlier calendar references cited October 31 as the upcoming earnings date, while the company’s announcement identifies November 2 as the conference-call date. The distinction is important because October 31 is the scheduled board meeting date and November 2 is the investor and analyst interaction date.

The November 2 call will allow shareholders and analysts to hear management’s commentary on financial performance and outlook after the results process. The company has not provided a numerical earnings forecast in the information available, so the reported results and management discussion will be the key official updates.

What did Rainbow Children's Medicare report in Q1 FY27?

Rainbow Children's Medicare reported Q1 FY27 revenue of ₹4.70 billion, up 33% from the comparable quarter a year earlier, while net income rose 13% to ₹0.61 billion. Earnings per share increased to ₹5.97 from ₹5.27 in Q1 FY26.

The quarterly update also said EBITDA increased 30% to ₹1.35 billion. Separately, standalone June 2026 net sales were reported at ₹4.11 billion, up 22.64% year-on-year. These figures refer to different reporting bases, with the source identifying the latter specifically as standalone net sales.

The Q1 release showed higher revenue and earnings compared with the preceding year’s June quarter. However, the available material does not provide a consensus forecast for Q2 FY27. As a result, comparisons after the result will depend on the company’s reported standalone and consolidated figures and the relevant prior-year base.

What is the comparison base for the September quarter?

Rainbow Children's Medicare reported Q2 FY26 revenue of ₹4.53 billion and net income of ₹0.75 billion, according to one of the reported quarterly summaries. That summary showed revenue growth of 8.5% year-on-year, while EPS declined to ₹7.41 from ₹7.77 and net income fell 4.6% from the prior-year quarter.

Another update described Q2 FY26 revenue as ₹4.45 billion, up 6.5% year-on-year, and profit after tax as ₹0.76 billion, down 4.3%. It attributed the slower period to lower occupancy arising from reduced seasonal illnesses and the early festive season. The figures differ slightly across the supplied updates, so readers should rely on the company’s filed financial statements for the definitive reported amount and reporting basis.

The Q2 FY26 update also said beds increased 6% and outpatient consultations rose 6%, although inpatient discharges declined slightly. The company had completed two strategic acquisitions and appointed Abrarali Dalal as chief executive officer effective January 20, 2026, according to the same update.

How do the latest results fit Rainbow Children's Medicare's annual performance?

Rainbow Children's Medicare’s FY26 revenue was reported at ₹17.50 billion, up 15% from FY25, while net income increased 14% to ₹2.78 billion. Full-year EPS rose to ₹27.41 from ₹23.97 in FY25.

The source also lists key details of ₹18.20 billion in revenue, ₹4.90 billion in cost of revenue, ₹13.30 billion in gross profit, ₹10.40 billion in other expenses and ₹2.90 billion in earnings. Because these figures are presented separately from the FY26 summary and without a stated matching period in the supplied information, they should not be treated as a direct replacement for the reported full-year figures.

Rainbow Children's Medicare operates a multi-specialty hospital chain focused on paediatrics, obstetrics and gynaecology in India. For investors, the Q2 FY27 release will provide an update on whether the first quarter’s revenue growth and the company’s operational expansion continued through the September period.

Why does the Q2 FY27 update matter to investors?

The Q2 FY27 update matters because it will provide the next official measure of revenue, profitability and operating activity after a first quarter that showed 33% revenue growth. It will also be compared with a Q2 FY26 period in which revenue grew at a slower rate and profit declined despite higher revenue.

Management’s comments on the November 2 call may offer context on occupancy, consultations, discharges and the contribution of acquisitions. These operating measures are relevant for a hospital operator because changes in patient volumes and bed capacity can affect revenue and costs. No outcome for the quarter can be inferred before the board-approved results are released.

Conclusion

Rainbow Children's Medicare has set October 31, 2026 for its board meeting on the September-quarter results and November 2 for its Q2 FY27 earnings conference call. The event follows Q1 FY27 revenue of ₹4.70 billion and net income of ₹0.61 billion, alongside FY26 revenue of ₹17.50 billion and net income of ₹2.78 billion.

Investors will next watch the unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026, and management’s commentary during the November 2 call. The company has not disclosed a numerical Q2 forecast in the available information.